Katherine Williams

Publications

• Differences in verbal memory performance in postmenopausal women receiving hormone therapy: 17β-estradiol versus conjugated equine estrogens. Wroolie TE, Kenna HA, Williams KE, Powers BN, Holcomb M, Khaylis A, Rasgon NL. Am J Geriatr Psychiatry. 2011; 19 (9): 792-802
• Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease. Rasgon NL, Kenna HA, Wroolie TE, Kelley R, Silverman D, Brooks J, Williams KE, Powers BN, Hallmayer J, Reiss A. Neurobiol Aging. 2011; 32 (11): 1942-8
• Mood disorders in oocyte donor candidates: brief report and implications for future research. Williams KE, Stemmle PG, Westphal LM, Rasgon NL. Hum Reprod. 2011; 26 (4): 847-52
• Rosiglitazone add-on in treatment of depressed patients with insulin resistance: a pilot study. Rasgon NL, Kenna HA, Williams KE, Powers B, Wroolie T, Schatzberg AF. ScientificWorldJournal. 2010: 10 321-8
• Cognitive effects of memantine in postmenopausal women at risk of dementia: a pilot study. Wroolie TE, Kenna HA, Williams KE, Powers BN, Holcomb M, Lazzeroni L, Rasgon NL. Acta Neurol Scand. 2009; 119 (3): 172-9
• Mood disorders and fertility in women: a critical review of the literature and implications for future research. Williams KE, Marsh WK, Rasgon NL. Hum Reprod Update. 2007 Nov-Dec; 13 (6): 607-16
• Mood and neuropsychological changes in women with midlife depression treated with escitalopram. Wroolie TE, Williams KE, Keller J, Zappert LN, Shelton SD, Kenna HA, Reynolds MF, Rasgon NL. J Clin Psychopharmacol. 2006; 26 (4): 361-6
• Obsessive-compulsive disorder in pregnancy, the puerperium, and the premenstruum. Williams KE, Koran LM. J Clin Psychiatry. 1997; 58 (7): 330-4; quiz 335-6